Repaglinide Good Manufacturer supply High Quality 135062-02-1
- Molecular Formula:C27H36N2O4
- Molecular Weight:452.594
- Appearance/Colour:white to off-white solid
- Vapor Pressure:5E-19mmHg at 25°C
- Melting Point:129-130.2 °C
- Refractive Index:1.567
- Boiling Point:672.9 °C at 760 mmHg
- PKA:4.19±0.10(Predicted)
- Flash Point:360.8 °C
- PSA：78.87000
- Density:1.137 g/cm3
- LogP:5.67580
Repaglinide (135062-02-1) Usage
Repaglinide is a metaglitinide antidiabetic agent that blocks ATP-dependent potassium (Kir6) channels in pancreatic β-cells (Kd = 0.42 nM for the sulphonylurea receptor SUR1 when co-expressed with Kir6.2). In vivo, repaglinide lowers blood glucose in fasted rats and dogs (ED50s = 10 and 28.3 μg/kg, respectively). Formulations containing repaglinide have been used to control blood sugar levels in patients with type 2 diabetes.
How to get the best price on Repaglinide?
Zibo Hangyu Biotechnology Development Co., Ltd is a quality supplier and manufacturer of Repaglinide . You can buy high quality, low price Repaglinide 135062-02-1 here.
Zibo Hangyu Biotechnology Development Co., Ltd. is a comprehensive chemical enterprise focusing on fine chemical products and pharmaceutical intermediates, integrating research and development, production and sales. The company is equipped with advanced equipment quality inspection and research center. At the same time, the company has excellent talents with rich experience in process development and quality control. To provide customers with total solutions from raw material processing to chemical synthesis systems. The company has established a standardized and perfect quality standard system to provide stable and high quality production and service.
Milestones
- 2012yearThe company was founded, began to engage in the production and supply of chemical raw materials
- 2014yearExpand the scale of production, pharmaceutical raw materials production workshop was established
- 2016yearCooperated with domestic and foreign chemical platforms to promote self-produced and high-end pharmaceutical intermediates
- 2019yearIn recent years to participate in the international pharmaceutical raw materials exhibitions
- 2023yearBusiness continues to expand, Production and Sales teams continue to grow
- 2026yearPlans to set up foreign branches
